LONDON (AFX) - VASTox PLC said the US regulators have granted a patent that provides further protection for its drug discovery programme in Duchenne Muscular Dystrophy (DMD). The AIM-listed biotechnology company said it is on target to announce by the end of the first half of 2007 a drug candidate that will go into pre-clinical development.
